TXG
$19.2
Revenue | $166.03Mn |
Net Profits | $-16.25Mn |
Net Profit Margins | -9.79% |
10x Genomics Inc’s revenue jumped 0.61% since last year same period to $166.03Mn in the Q4 2025. On a quarterly growth basis, 10x Genomics Inc has generated 11.43% jump in its revenue since last 3-months.
10x Genomics Inc’s net profit jumped 66.85% since last year same period to $-16.25Mn in the Q4 2025. On a quarterly growth basis, 10x Genomics Inc has generated 40.84% jump in its net profits since last 3-months.
10x Genomics Inc’s net profit margin jumped 67.05% since last year same period to -9.79% in the Q4 2025. On a quarterly growth basis, 10x Genomics Inc has generated 46.91% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.28 |
EPS Estimate Current Year | -0.28 |
10x Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a -31.06% fall from last quarter’s estimates.
10x Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.28.
Earning Per Share (EPS) | 0 |
10x Genomics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the 10x Genomics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-06 | -0.28 | 0 | 100% |